Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe): clinical case with unique confirmatory testing.

Stellpflug SJ, Kealey SE, Hegarty CB, Janis GC.

J Med Toxicol. 2014 Mar;10(1):45-50. doi: 10.1007/s13181-013-0314-y.

2.

Studies on the metabolism and toxicological detection of the new psychoactive designer drug 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) in human and rat urine using GC-MS, LC-MS(n), and LC-HR-MS/MS.

Caspar AT, Helfer AG, Michely JA, Auwärter V, Brandt SD, Meyer MR, Maurer HH.

Anal Bioanal Chem. 2015 Sep;407(22):6697-719. doi: 10.1007/s00216-015-8828-6. Epub 2015 Jun 25.

PMID:
26108532
3.

Analysis of 25I-NBOMe, 25B-NBOMe, 25C-NBOMe and Other Dimethoxyphenyl-N-[(2-Methoxyphenyl) Methyl]Ethanamine Derivatives on Blotter Paper.

Poklis JL, Raso SA, Alford KN, Poklis A, Peace MR.

J Anal Toxicol. 2015 Oct;39(8):617-23. doi: 10.1093/jat/bkv073.

4.

Identification of Metabolite Biomarkers of the Designer Hallucinogen 25I-NBOMe in Mouse Hepatic Microsomal Preparations and Human Urine Samples Associated with Clinical Intoxication.

Poklis JL, Dempsey SK, Liu K, Ritter JK, Wolf C, Zhang S, Poklis A.

J Anal Toxicol. 2015 Oct;39(8):607-16. doi: 10.1093/jat/bkv079.

5.

2C-I-NBOMe, an "N-bomb" that kills with "Smiles". Toxicological and legislative aspects.

Nikolaou P, Papoutsis I, Stefanidou M, Spiliopoulou C, Athanaselis S.

Drug Chem Toxicol. 2015 Jan;38(1):113-9. doi: 10.3109/01480545.2014.911882. Epub 2014 May 1. Review.

PMID:
24785196
6.

High-performance liquid chromatography tandem mass spectrometry method for the determination of 2CC-NBOMe and 25I-NBOMe in human serum.

Poklis JL, Charles J, Wolf CE, Poklis A.

Biomed Chromatogr. 2013 Dec;27(12):1794-800. doi: 10.1002/bmc.2999. Epub 2013 Jul 25.

7.

Postmortem detection of 25I-NBOMe [2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine] in fluids and tissues determined by high performance liquid chromatography with tandem mass spectrometry from a traumatic death.

Poklis JL, Devers KG, Arbefeville EF, Pearson JM, Houston E, Poklis A.

Forensic Sci Int. 2014 Jan;234:e14-20. doi: 10.1016/j.forsciint.2013.10.015. Epub 2013 Oct 18.

8.

Evolution of the NBOMes: 25C- and 25B- Sold as 25I-NBOMe.

Laskowski LK, Elbakoush F, Calvo J, Exantus-Bernard G, Fong J, Poklis JL, Poklis A, Nelson LS.

J Med Toxicol. 2015 Jun;11(2):237-41. doi: 10.1007/s13181-014-0445-9.

9.

Bad trip due to 25I-NBOMe: a case report from the EU project SPICE II plus.

Hermanns-Clausen M, Angerer V, Kithinji J, Grumann C, Auwärter V.

Clin Toxicol (Phila). 2017 Sep;55(8):922-924. doi: 10.1080/15563650.2017.1319572. Epub 2017 May 4.

PMID:
28471280
10.

Prevalence of use and acute toxicity associated with the use of NBOMe drugs.

Wood DM, Sedefov R, Cunningham A, Dargan PI.

Clin Toxicol (Phila). 2015 Feb;53(2):85-92. doi: 10.3109/15563650.2015.1004179.

PMID:
25658166
11.

Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response.

Halberstadt AL, Geyer MA.

Neuropharmacology. 2014 Feb;77:200-7. doi: 10.1016/j.neuropharm.2013.08.025. Epub 2013 Sep 4.

12.

NBOMe designer drug exposures reported to Texas poison centers.

Forrester MB.

J Addict Dis. 2014;33(3):196-201. doi: 10.1080/10550887.2014.950027.

PMID:
25115175
13.

25I-NBOMe related death in Australia: a case report.

Kueppers VB, Cooke CT.

Forensic Sci Int. 2015 Apr;249:e15-8. doi: 10.1016/j.forsciint.2015.02.010. Epub 2015 Feb 18.

PMID:
25747271
14.

Schedules of Controlled Substances: Extension of Temporary Placement of Three Synthetic Phenethylamines in Schedule I. Final order.

Drug Enforcement Administration, Department of Justice.

Fed Regist. 2015 Nov 13;80(219):70657-9.

15.

Case series: toxicity from 25B-NBOMe--a cluster of N-bomb cases.

Gee P, Schep LJ, Jensen BP, Moore G, Barrington S.

Clin Toxicol (Phila). 2016;54(2):141-6. doi: 10.3109/15563650.2015.1115056. Epub 2015 Dec 1.

PMID:
26621342
16.

Retrospective demonstration of 25I-NBOMe acute poisoning using hair analysis.

Ameline A, Farrugia A, Raul JS, Kintz P.

Curr Pharm Biotechnol. 2017 Nov 29. doi: 10.2174/1389201019666171129175148. [Epub ahead of print]

PMID:
29189143
17.

Analytical characterization of three hallucinogenic N-(2-methoxy)benzyl derivatives of the 2C-series of phenethylamine drugs.

Zuba D, Sekuła K.

Drug Test Anal. 2013 Aug;5(8):634-45. doi: 10.1002/dta.1397. Epub 2012 Aug 31.

PMID:
22936468
18.
19.

Schedules of controlled substances: temporary placement of three synthetic phenethylamines into Schedule I. Final order.

Drug Enforcement Administration. Department of Justice.

Fed Regist. 2013 Nov 15;78(221):68716-9.

20.

Severe clinical toxicity associated with analytically confirmed recreational use of 25I-NBOMe: case series.

Hill SL, Doris T, Gurung S, Katebe S, Lomas A, Dunn M, Blain P, Thomas SH.

Clin Toxicol (Phila). 2013 Jul;51(6):487-92. doi: 10.3109/15563650.2013.802795. Epub 2013 Jun 4.

PMID:
23731373

Supplemental Content

Support Center